Ren Y J, Liu Q M, Ge M H, Li H Z, Liu B, Zhang Y, Du L B
Institute of Chronic Noncommunicable Diseases Prevention and Control, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, China.
Department of Cancer Prevention, Zhejiang Province People's Hospital, Hangzhou 310014, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Oct 6;53(10):1062-1065. doi: 10.3760/cma.j.issn.0253-9624.2019.10.021.
From 2010 to 2014, a total of 17 150 new cases of thyroid cancer (TC) reported in cancer registration areas of Zhejiang province, the crude incidence rate of TC was 29.28/100 000. Using the Chinese Census in 2000 and the World Segi's population as the standard population, the age-standardized incidence rate by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 24.11/100 000 and 20.65/100 000 respectively. 256 TC death cases reported in all, the crude mortality rate was 0.44/100 000, the age-standardized mortality rate by Chinese standard population (ASMRC) and by World standard population (ASMRW) were 0.23/100 000 and 0.23/100 000 respectively. The ASIRC had a upward trend [annual percent change (APC)=28.62%, 95: 21.00%-36.72%, 13.10, 0.001], while the ASMRC trend seemed stable (APC=0.73%, 95: -7.47%-9.66%, 0.27, 0.803).
2010年至2014年,浙江省癌症登记地区共报告17150例甲状腺癌新发病例,甲状腺癌粗发病率为29.28/10万。以2000年中国人口普查数据和世界Segi人口作为标准人口,中国标准人口年龄标准化发病率(ASIRC)和世界标准人口年龄标准化发病率(ASIRW)分别为24.11/10万和20.65/10万。共报告256例甲状腺癌死亡病例,粗死亡率为0.44/10万,中国标准人口年龄标准化死亡率(ASMRC)和世界标准人口年龄标准化死亡率(ASMRW)均为0.23/10万。ASIRC呈上升趋势[年度百分比变化(APC)=28.62%,95%可信区间:21.00%-36.72%,P=0.001],而ASMRC趋势似乎稳定(APC=0.73%,95%可信区间:-7.47%-9.66%,P=0.803)。